Literature DB >> 26969484

The purinergic receptor P2X7 role in control of Dengue virus-2 infection and cytokine/chemokine production in infected human monocytes.

Gladys Corrêa1, Carolina de A Lindenberg2, Caroline Fernandes-Santos2, Mariana Gandini2, Fabienne Petitinga Paiva2, Robson Coutinho-Silva3, Claire F Kubelka2.   

Abstract

Purinergic signaling has a crucial role in intracellular pathogen elimination. The P2X7 purinergic receptor (P2X7R), once activated by ATP, leads to pro-inflammatory responses including reactive oxygen species production. ATP can be released by injured cells, as endogenous danger signals. Dengue fever may evolve to a severe disease, leading to hypovolemic shock and coagulation dysfunctions as a result of a cytokine storm. Our aim was to evaluate the role of P2X7R activation during Dengue virus (DENV) infection. Extracellular ATP inhibited viral load in pretreated monocytes, as measured by NS1 secretion and by decrease in DENV(+) P2X7(+) cell frequencies, suggesting that P2X7R is involved in the antiviral response. Nitric oxide (NO) has anti-DENV properties and is decreased after DENV infection. NO production after ATP stimulation is abrogated by KN62 treatment, a specific P2X7R inhibitor, indicating that P2X7R likely is acting in the virus containment process. Additionally, TNF, CXCL8, CCL2 and CXCL10 factors that are associated with dengue severity were modulated by the P2X7R activation. We conclude that P2X7R is directly involved in the modulation of the antiviral and inflammatory process that occurs during DENV infection in vitro, and may have an important role in patient recovery in a first moment.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Dengue; Monocytes; P2X7 receptor; Purinergic signaling

Mesh:

Substances:

Year:  2016        PMID: 26969484     DOI: 10.1016/j.imbio.2016.02.003

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  15 in total

Review 1.  Purinergic receptors and neglected tropical diseases: why ignore purinergic signaling in the search for new molecular targets?

Authors:  P A F Pacheco; L P Dantas; L G B Ferreira; Robson Xavier Faria
Journal:  J Bioenerg Biomembr       Date:  2018-06-07       Impact factor: 2.945

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

3.  ENPP1's regulation of extracellular cGAMP is a ubiquitous mechanism of attenuating STING signaling.

Authors:  Jacqueline A Carozza; Anthony F Cordova; Jenifer A Brown; Yasmeen AlSaif; Volker Böhnert; Xujun Cao; Rachel E Mardjuki; Gemini Skariah; Daniel Fernandez; Lingyin Li
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-19       Impact factor: 12.779

Review 4.  Innate Immune Response to Dengue Virus: Toll-like Receptors and Antiviral Response.

Authors:  Caroline Fernandes-Santos; Elzinandes Leal de Azeredo
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

Review 5.  The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2.

Authors:  Davide Ferrari; Michele Rubini; Jorge S Burns
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

Review 6.  P2RX7 at the Host-Pathogen Interface of Infectious Diseases.

Authors:  Alexandra Y Soare; Tracey L Freeman; Alice K Min; Hagerah S Malik; Elizabeth O Osota; Talia H Swartz
Journal:  Microbiol Mol Biol Rev       Date:  2021-01-13       Impact factor: 11.056

7.  Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection.

Authors:  Victor H Leyva-Grado; Megan E Ermler; Michael Schotsaert; Ma G Gonzalez; Virginia Gillespie; Jean K Lim; Adolfo García-Sastre
Journal:  MBio       Date:  2017-03-28       Impact factor: 7.867

Review 8.  The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?

Authors:  Luiz E B Savio; Paola de Andrade Mello; Cleide Gonçalves da Silva; Robson Coutinho-Silva
Journal:  Front Pharmacol       Date:  2018-02-06       Impact factor: 5.810

Review 9.  The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.

Authors:  Geoffrey Burnstock; Gillian E Knight
Journal:  Purinergic Signal       Date:  2017-11-21       Impact factor: 3.765

10.  The Pannexin 1/Purinergic Receptor P2X4 Pathway Controls the Secretion of MicroRNA-Containing Exosomes by HCV-Infected Hepatocytes.

Authors:  Ok-Kyung Kim; Da-Eun Nam; Young S Hahn
Journal:  Hepatology       Date:  2021-08-30       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.